Research ArticleHead and Neck Imaging
Prediction of Treatment Response in Head and Neck Cancer by Magnetic Resonance Spectroscopy
Tedros Bezabeh, Olva Odlum, Richard Nason, Paul Kerr, Donna Sutherland, Rakesh Patel and Ian C.P. Smith
American Journal of Neuroradiology September 2005, 26 (8) 2108-2113;
Tedros Bezabeh
Olva Odlum
Richard Nason
Paul Kerr
Donna Sutherland
Rakesh Patel

References
- ↵American Cancer Society. Cancer facts and figures 2004. Atlanta: American Cancer Society
- ↵Chisholm GD, Hedlund PO, Adolfsson J, et al. The TNM system of 1992: Comments from the TNM working group. Scand J Urol Nephrol Suppl 1994;162:107–114
- ↵Wennerberg J. Predicting response to therapy of squamous cell carcinoma of the head and neck [review]. Anticancer Res 1996;16:2389–2396
- ↵
- ↵
- ↵Syms CA 3rd, Eibling DE, McCoy JP Jr, et al. Flow cytometric analysis of primary and metastatic squamous cell carcinoma of the oral cavity and oropharynx. Laryngoscope 1995;105:149–155
- ↵Raybaud-Diogene H, Tetu B, Morency R, Fortin A, Monteil RA. p53 overexpression in head and neck squamous cell carcinoma. Eur J Cancer B Oral Oncol 1996;32:143–149
- ↵Field JK, Malliri A, Butt SA. p53 overexpression in end stage squamous cell carcinoma of the head and neck: correlates with a very poor clinical outcome. Int J Oncol 1993;3:431–435
- ↵Dolcetti R, Doglioni C, Maestro R, et al. p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: genetic and prognostic implications. Int J Cancer 1992;52:178–182
- ↵Frank JL, Bur ME, Garb JL, et al. p53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx. Cancer 1994;73:181–186
- ↵Anneroth G, Batsakis J, Luna M. Review of the literature and recommended system of malignant grading in oral squamous cell carcinomas. Scand J Dent Res 1987;95:229–249
- ↵Bezabeh T, Smith ICP, Krupnik E, et al. Diagnostic potential for cancer via 1H magnetic resonance spectroscopy of colon tissue. Anticancer Res 1996;16:1553–1558
- Bezabeh T, El-Sayed S, Patel R, et al. Statistical classification strategy for proton magnetic resonance spectra of soft tissue sarcoma: an exploratory study with potential clinical utility. Sarcoma 2002;6:97–103
- ↵Hahn P, Smith ICP, Leboldus L, Littman C, Somorjai RL, Bezabeh T. The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra. Cancer Res 1997;57:3398–3401
- Wallace JC, Raaphorst GP, Somorjai RL, et al. Classification of 1H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis. Magn Reson Med 1997;38:569–576
- ↵Somorjai RL, Nikulin AE, Pizzi N, et al. Computerized consensus diagnosis: a classification strategy for the robust analysis of MR spectra. I. Application to 1H spectra of thyroid neoplasms. Magn Reson Med 1995;33:257–263
- ↵Mountford CE, Somorjai RL, Malycha P, et al. Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy. Br J Surg 2001;88:1234–1240
- ↵Mukherji SK, Schiro S, Castillo M, Kwock L, Muller KE, Blackstock W. Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies. AJNR Am J Neuroradiol 1997;18:1057–1072
- ↵Mukherji SK, Schiro S, Castillo M, et al. Proton MR spectroscopy of squamous cell carcinoma of the upper aerodigestive tract: in vitro characteristics. AJNR Am J Neuroradiol 1996;17:1485–1490
- Maheshwari SR, Mukherji SK, Neelon B, et al. The choline/creatine ratio in five benign neoplasms: comparison with squamous cell carcinoma by use of in vitro MR spectroscopy. AJNR Am J Neuroradiol 2000;21:1930–1935
- Gerstle RJ, Aylward SR, Kromhout-Schiro S, Mukherji SK. The role of neural networks in improving the accuracy of MR spectroscopy for the diagnosis of head and neck squamous cell carcinoma. AJNR Am J Neuroradiol 2000;21:1133–1138
- ↵King AD, Yeung DK, Ahuja AT, et al. In vivo proton MR spectroscopy of primary and nodal nasopharyngeal carcinoma. AJNR Am J Neuroradiol 2004;25:484–490
- ↵
- ↵Kuesel AC, Kroft T, Saunders JK, et al. A simple procedure for obtaining high-quality NMR spectra of semiquantitative value from small tissue specimens: cervical biopsies. Magn Reson Med 1992;27:349–355
- ↵Griffiths JR, Tate AR, Howe FA, Stubbs M; Group on MRS Application to Cancer. Magnetic resonance spectroscopy of cancer-practicalities of multi-centre trials and early results in non-Hodgkin’s lymphoma. Eur J Cancer 2002;38:2085–2093
- ↵Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992;5:303–324
- ↵Leach MO. Introduction to in vivo MRS of cancer: new perspectives and open problems. Anticancer Res 1996;16:1503–1514
- ↵Degani H, Ronen SM, Furman-Haran E. Breast cancer: spectroscopy and imaging of cells and tumors. In: Gillies RJ, ed. NMR in physiology and biomedicine. San Diego: Academic Press;1994;329–352
- ↵Aboagye EO, Bhujwalla ZM. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 1999;59:80–84
- ↵Bhujwalla ZM, Aboagye EO, Gillies RJ, Chacko VP, Mendola CE, Backer JM. Nm23-transfected MDA-MB-435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: a 31P nuclear magnetic resonance study in vivo and vitro. Magn Reson Med 1999;41:897–903
- ↵Bezabeh T, El-Sayed S, Odlum O, et al. Grading of head and neck tumors by 1H MRS: an approach with potential clinical utility. Proc Int Soc Magn Reson Abst 2001;9:2348 [abstract]
- ↵Tedeschi G, Lundbom N, Raman R, et al. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 1997;87:516–524
- ↵Wald LL, Nelson SJ, Day MR, et al. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg 1997;87:525–534
- ↵
- ↵Mackinnon WB, Barry PA, Malycha PL, et al. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology 1997;204:661–666
- ↵Tarnawski R, Sokol M, Pieniazek P, et al. 1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys 2002;52:1271–1276
- ↵Brizel DM, Schroeder T, Scher RL, et al. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;51:349–353
- ↵Okada A, Takehara H, Yoshida K, et al. Increased aspartate and glutamate levels in both gastric and colon cancer tissues. Tokushima J Exp Med 1993;40:19–25
- ↵Bezabeh T, Somorjai RL, Smith ICP, et al. The use of 1H magnetic resonance spectroscopy in the study of inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn’s disease. Am J Gastroenterol 2001;96:442–48
- ↵Huang W, Roche P, Shindo M, et al. Evaluation of head and neck tumor response to therapy using in vivo 1H MR spectroscopy: correlation with pathology. Proc Int Soc Magn Reson Abst 2000;8:552 [abstract]
In this issue
Advertisement
Tedros Bezabeh, Olva Odlum, Richard Nason, Paul Kerr, Donna Sutherland, Rakesh Patel, Ian C.P. Smith
Prediction of Treatment Response in Head and Neck Cancer by Magnetic Resonance Spectroscopy
American Journal of Neuroradiology Sep 2005, 26 (8) 2108-2113;
0 Responses
Jump to section
Related Articles
- No related articles found.
Cited By...
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement